140 related articles for article (PubMed ID: 28473530)
1. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients.
Udumyan R; Montgomery S; Duberg AS; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Scand J Gastroenterol; 2020 May; 55(5):597-605. PubMed ID: 32412855
[No Abstract] [Full Text] [Related]
3. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
Udumyan R; Botteri E; Jerlstrom T; Montgomery S; Smedby KE; Fall K
Acta Oncol; 2022 Aug; 61(8):922-930. PubMed ID: 35881046
[TBL] [Abstract][Full Text] [Related]
5. Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer.
Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):119-126. PubMed ID: 31641010
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
[TBL] [Abstract][Full Text] [Related]
7. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
8. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
[TBL] [Abstract][Full Text] [Related]
9. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
10. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway.
Støer NC; Bouche G; Pantziarka P; Sloan EK; Andreassen BK; Botteri E
Acta Oncol; 2021 Sep; 60(9):1146-1153. PubMed ID: 34338111
[TBL] [Abstract][Full Text] [Related]
11. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
12. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer; reporting and long-term survival in Sweden.
Lambe M; Eloranta S; Wigertz A; Blomqvist P
Acta Oncol; 2011 Nov; 50(8):1220-7. PubMed ID: 21812626
[TBL] [Abstract][Full Text] [Related]
14. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Saad A; Goldstein J; Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Mouallem M; Goldstein A; Giantonio B; Boursi B
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):599-604. PubMed ID: 32196836
[TBL] [Abstract][Full Text] [Related]
15. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
18. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
[TBL] [Abstract][Full Text] [Related]
19. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
20. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Allen LaPointe NM; Zhou Y; Stafford JA; Hernandez AF; Kramer JM; Anstrom KJ
Am J Cardiol; 2009 Jun; 103(11):1518-24. PubMed ID: 19463509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
